Evidence map›Paper›PMID 39035835›Full record

ReviewComputational and structural biotechnology journal2024

Heterogeneous network approaches to protein pathway prediction.

Gowri Nayar, Russ B Altman

Abstract readReview
In one paragraph

Review in Computational and structural biotechnology journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Graph-Based Gene Embedding.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gowri NayarDepartment of Biomedical Data Science, Stanford University, United States.
Russ B AltmanDepartment of Biomedical Data Science, Stanford University, United States.

Funding

Computational methods for characterizing sources of variability in drug responseR35GM153195 · NIGMS · STANFORD UNIVERSITY · PI RUSS BIAGIO ALTMAN · 2024 to 2026
$1.0M
Exploring Understudied Proteins to Predict Novel Pathways and Associations to DiseaseF31LM014646 · NLM · STANFORD UNIVERSITY · PI NAYAR, GOWRI · 2024 to 2025
$92k
NIGMS NIH HHS R35 GM153195NLM NIH HHS F31 LM014646
6 · The paper itself

Abstract

Understanding protein-protein interactions (PPIs) and the pathways they comprise is essential for comprehending cellular functions and their links to specific phenotypes. Despite the prevalence of molecular data generated by high-throughput sequencing technologies, a significant gap remains in translating this data into functional information regarding the series of interactions that underlie phenotypic differences. In this review, we present an in-depth analysis of heterogeneous network methodologies for modeling protein pathways, highlighting the critical role of integrating multifaceted biological data. It outlines the process of constructing these networks, from data representation to machine learning-driven predictions and evaluations. The work underscores the potential of heterogeneous networks in capturing the complexity of proteomic interactions, thereby offering enhanced accuracy in pathway prediction. This approach not only deepens our understanding of cellular processes but also opens up new possibilities in disease treatment and drug discovery by leveraging the predictive power of comprehensive proteomic data analysis.

Indexed as

EmbeddingsFunctional proteomicsHeterogeneous networksPathway predictionProtein pathways

Identifiers

PMID39035835
PMCPMC11260399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.